Creative Biostructure

Online Inquiry

Please enter "biostructure" as the verification code.
Name
RSV-F VLP
Cat No.
CBS-V044
Virus Family
Pneumoviridae
Composition
Fusion protein (F)
Source
Insect recombinant
Protein Conc.
1.0-1.5 mg/mL
Purity
>95% by SDS-PAGE
Presentation
20mM Tris-HCl, pH 7.5, 250 mM NaCl.
Description
Respiratory syncytial virus (RSV) is a very serious pathogen in several different human populations. The virus is the most significant viral cause of lower respiratory tract infections in infants and young children. VLPs containing the pre-fusion RSV F protein have characteristics required for a safe, effective RSV vaccine.

We provide highly purified Virus-Like Particles (VLPs) products as antigens, produced in a native format, mostly using a mammalian expression system. Custom VLPs synthesis is also offered presented as a cell lysate or a purified antigen for use in vaccine development (including use as an immunogen) and serological based diagnostic assays. We like to be in touch with our customers so please feel free to contact us for a formal quote.

Ordering process

Ordering Process